Reduced proliferation rate of hypoxanthine-phosphoribosyl transferase mutant human T-lymphocytes in vitro

Environmental and Molecular Mutagenesis

Volumn 28, Issue 1, 1996, Pages 13-18

  Podlutsky, Andrej ^a   Bastlová, Tatiana ^a   Lambert, Bo ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CNT Novum   (Sweden)

Author keywords

hprt mutation; Mutant frequency; Reduced growth rate; T lymphocytes

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; STYRENE;

ADULT; ARTICLE; CELL MUTANT; CELL PROLIFERATION; CLONING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; T LYMPHOCYTE;

ADULT; CELL DIVISION; CLONE CELLS; FEMALE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MIDDLE AGED; MUTATION; T-LYMPHOCYTES;

EID: 0029748639     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1996)28:1<13::AID-EM4>3.0.CO;2-F     Document Type: Article

References (30)

1. Albertini RJ, DeMars R (1974): Mosaicism of peripheral blood lymphocyte populations in females heterozygous for the Lesch-Nyhan mutation. Biochem Genet 11:397-411.
2. Albertini RJ, Castle KL, Borcherding WR (1982): T-cell cloning to detect the mutant 6-thioguanine resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci USA 79:6617-6621.
3. Albertini RJ, O'Neill P, Nicklas JA, Heintz NH, Kelleher PC (1985): Alterations of the hprt gene in human in vivo derived 6-thioguanine resistant T-lymphocytes. Nature 316:369-371.
4. Andersson B, Hou S-M, Lambert B (1992a): Mutations causing defective splicing in the human hprt gene. Environ Mol Mutagen 20:89-95.
5. Andersson B, Fal̈t S, Lambert B (1992b): Strand specificity for mutations induced by (+)-anti BPDE in the hprt gene in human Tlymphocytes. Mutat Res 269:129-140.
6. Bastlová T, Vodic̃ka P, Peterková K, Hemminki K, Lambert B (1995): Styrene oxide-induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human T-lymphocytes. Carcinogenesis 16:2357-2362.
7. Bastlová T, Podlutsky A (1996): Molecular analysis of styrene oxideinduced hprt mutation in human T-lymphocytes. Mutagenesis (in press).
8. Burkhart-Schultz K, Thomas CB, Thompson CL, Strout CL, Brinson E, Jones LM (1993): Characterization of in vivo somatic mutations at the hypoxanthine phosphoribosyltransferase gene of a human control population. Environ Health Perspect 101:68-74.
9. Cariello NF (1994): Software for the analysis of mutations at the human hprt gene. Mutat Res 312:173-185.
10. Cariello NF, Skopek TR (1993a): In vivo mutation at the human HPRT locus. Trends Genet 9:322-326.
11. Cariello NF, Skopek TR (1993b): Analysis of mutations occurring at the human hprt locus. J Mol Biol 231:41-57.
12. Cole J, Skopek T (1994): Somatic mutation frequency, mutation rates and mutation spectra in the human population in vivo. Mutat Res 304:33-106.
13. Dempsey JL, Morley AA, Seshadri RS, Emerson BT, Gordon R, Bhagat CI (1983): Detection of the carrier state for an X-linked disorder, the Lesch-Nyhan syndrome, by the use of lymphocyte cloning. Hum Genet 64:288-290.
14. Edwards A, Voss H, Rice P, Civitello A, Stegemann J, Schwager C, Zimmerman J, Erfle H, Caskey CT (1990): Automated DNA sequencing of the human hprt-locus. Genomics 6:593-608.
15. Hou S-M, Steen A-M, Fäit S, Andersson, B (1993): Molecular spectrum of background mutation at the hprt locus in human T-lymphocytes. Mutagenesis 8:43-49.
16. Hou S-M, Fäit S, Steen A-M (1995): HPRT mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ Mol Mutagen 25:97-105.
17. McGregor WG, Maher VM, McCormick JJ (1994): Kinds and location of mutations induced in the hypoxanthine-guanine phosphoribo- syltransferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase. Cancer Res 54:4207-4213.
18. Morley AA, Trainor KJ, Seshadri R, Ryall RB (1983): Measurement of in vivo mutations in human lymphocytes. Nature 302:155-156.
19. O'Neill JP, Sullivan LM, Albertini RJ (1990): In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes. Mutat Res 240:135-142.
20. O'Neill JP, Sullivan LM, Hunter TC, Nicklas JA (1991): Cytosine arabinoside enhancement of gamma irradiation induced mutations in human T-lymphocytes. Environ Mol Mutagen 17:231-237.
21. Recio L, Cochrane J, Simpson D, Skopek TR, O'Neill JP, Nicklas JA, Albertini RJ (1990): DNA sequence analysis of in vivo hprt mutation in human T-lymphocytes. Mutagenesis 5:505-510.
22. Rossi AM, Tales AD, van Zeeland AA, Vrieling H (1992): Molecular analysis of mutations affecting hprt mRNA splicing in human T-lymphocytes in vivo. Environ Mol Mutagen 19:7-13.
23. Sanderson BJS, Dempsey JL, Morley AA (1984): Mutations in human lymphocytes: Effect of X- and UV-irradiation. Mutat Res 140:223-227.
24. Steen A-M, Sahlén S, Lambert B (1991): Expression of the hypoxanthine phosphoribosyl transferase gene in resting and growth-stimulated human lymphocytes. Biochem Biophys Acta 1088:77-85.
25. Steingrimsdottir H, Rowley G, Dorado G, Cole J, Lehmann AR (1992): Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res 20:1201-1208.
26. Steingrimsdottir H, Rowley G, Waugh A, Beare D, Ceccherini I, Cole J, Lehmann AR (1993): Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutat Res 294:29-41.
27. Thilly WG, deLuca JG, Hoppe H IV, Penman BW (1976): Mutation of human lymphoblasts by methylnitrosourea. Chem Biol Interactions 15:33-50.
28. Thilly WG, deLuca JG, Hoppe H IV, Penman BW (1978): Phenotypic lag and mutation to 6-thioguanine resistance in diploid human lymphoblasts. Mutat Res 50:137-144.
29. 6-guanine DNA adducts, DNA strand breaks and mutant frequencies at the hypoxanthine-guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis 16:1473-1481.
30. Vrieling H, Thijssen JCP, Rossi AM, van Dam FJ, Natarajan AT, Tates AD, van Zeeland AA (1992): Enhanced hprt mutant frequency but no significant difference in mutation spectrum between a smoking and a non-smoking human population. Carcinogenesis 13:1625-1631.